Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Total Current Liabilities: 2010-2021

Historic Total Current Liabilities for Neurocrine Biosciences (NBIX) over the last 11 years, with Sep 2021 value amounting to $225.9 million.

  • Neurocrine Biosciences' Total Current Liabilities fell 63.03% to $225.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $225.9 million, marking a year-over-year decrease of 63.03%. This contributed to the annual value of $186.5 million for FY2020, which is 67.01% down from last year.
  • Latest data reveals that Neurocrine Biosciences reported Total Current Liabilities of $225.9 million as of Q3 2021, which was up 6.11% from $212.9 million recorded in Q2 2021.
  • Neurocrine Biosciences' 5-year Total Current Liabilities high stood at $611.0 million for Q3 2020, and its period low was $23.6 million during Q1 2017.
  • Moreover, its 3-year median value for Total Current Liabilities was $190.0 million (2021), whereas its average is $272.1 million.
  • As far as peak fluctuations go, Neurocrine Biosciences' Total Current Liabilities soared by 1,096.61% in 2018, and later plummeted by 74.66% in 2019.
  • Quarterly analysis of 5 years shows Neurocrine Biosciences' Total Current Liabilities stood at $54.4 million in 2017, then surged by 62.12% to $88.2 million in 2018, then surged by 540.69% to $565.3 million in 2019, then slumped by 67.01% to $186.5 million in 2020, then crashed by 63.03% to $225.9 million in 2021.
  • Its last three reported values are $225.9 million in Q3 2021, $212.9 million for Q2 2021, and $190.0 million during Q1 2021.